The Act 73 to Act 60 Conversion Question Nobody Wants to Run

There is a particular kind of inertia that affects companies holding older Puerto Rico decrees.

The decree works. Benefits arrive. Compliance happens the way it has always happened. Nobody has a problem, and the person who negotiated the original grant may have retired. Under those conditions, nobody volunteers to reopen the question.

That is understandable, and it is occasionally expensive.

First, the vocabulary

Act 73-2008 (Legacy) is the superseded Economic Incentives for the Development of Puerto Rico Act. It pre-dates Act 60-2019, the Puerto Rico Incentives Code, which consolidated the island's incentive statutes into the current framework governing all new decrees and new R&D credit claims.

The same pattern applies to other pre-2019 statutes: Act 83-2010 (Legacy) for green energy, Acts 20 and 22 of 2012 (Legacy) for export services and resident investors.

If you hold a grandfathered decree under one of these, your benefits continue on the terms of the original grant. You are not doing anything wrong, and nobody is going to take it away because the law changed. But you are operating under terms that were negotiated against a different statute, a different economy and probably a different version of your own business.

The question that is actually being asked

It is not "which law is better." That framing produces no useful answer.

The real question is narrower: do the terms you already hold beat the terms you could negotiate today, given what your operation looks like now rather than what it looked like when the decree was issued?

That comparison has several moving parts.

What does your remaining decree term actually provide, read as written rather than as remembered? What would a current Act 60-2019 decree provide for the activity you perform today? How much remaining term do you have, and how does that change the calculation? And critically, what has changed about your operation since the original grant?

That last one is where the interesting answers usually come from.

Why operations drift away from their decrees

Decrees describe a business at a moment in time. Businesses then keep moving.

A manufacturing operation that added a substantial process development group is doing something materially different from what it was doing ten years ago. A plant that took on new product introduction responsibility has a different activity profile. A company that built out analytical or engineering capability on the island has shifted where its value is created.

None of those changes announce themselves to the decree. But they can change which framework serves the operation better, and they can mean that research activity is being performed without the credit position that current law provides for it.

That is the most common finding we see: a grandfathered decree holder doing genuinely qualifying research under a grant that was never designed around it.

The research credit specifically

Under Act 60-2019, the research and development activity credit at §3030.01 is modeled at two fixed rates: 50 percent on direct R&D investment deployed in Puerto Rico into experimental activities, 20 percent on indirect R&D investment deployed outside Puerto Rico or into incidental activities.

Whether and how a grandfathered decree holder can access that depends entirely on the terms of their own grant, which is why the conversion analysis starts with reading the actual instrument rather than reasoning from the statute.

We have had both conversations. Some clients look at the analysis and stay exactly where they are, correctly. Others find that their current activity profile is poorly served by a grant negotiated for a different business.

Neither answer is the default.

Why nobody runs the analysis

Three reasons, and they are all human rather than technical.

Nobody owns it. The decree lives with whoever handles compliance, and compliance is a maintenance function rather than a strategy function. Reopening the framework question is not on anyone's objectives.

The current position feels safe. There is a strong instinct that a known benefit beats an uncertain negotiation, even when the analysis might favor the latter.

And it looks like work. It is work, though less than people assume, and it is work with a quantifiable answer at the end.

What the analysis actually requires

Reading the decree instrument carefully, as written. Documenting what the operation currently does, particularly any research or development activity that has grown since issuance. Modeling the remaining grandfathered term against what a current framework position would provide. And understanding the conditions, obligations and timing considerations that apply to any conversion.

That is a bounded exercise. It produces a clear recommendation, which is frequently to do nothing.

The value is in knowing rather than assuming.

The timing element

Conversion is a decision with timing consequences rather than an administrative formality available indefinitely on the same terms. Remaining decree term affects the calculation, and the regulatory environment itself continues to develop — the Act 38-2026 amendments and the 31 December 2026 filing window are live considerations for some chapters.

That is a reason to run the analysis deliberately rather than reactively, not a reason to panic.

The disclaimer, which matters here

Nothing in this article tells you whether to convert. Your position depends on the specific terms of your decree instrument, your current activity, your remaining term and current administrative practice. This is indicative advisory context and should be confirmed for your situation.

The practical suggestion

If you hold a pre-2019 decree and nobody has formally compared it against current framework terms in the last few years, that is worth a conversation.

Not because the answer is necessarily conversion. Because "we have always been on the old decree" is not an analysis, and at some point someone on your board is going to ask whether anyone has checked.